Drawing for BODY-AID

USPTO serial 87180409

BODY-AID

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
STRUCK, ROBERT J
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BODY-AID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William Fitzpatrick

WILLIAM FITZPATRICK Eandi Fitzpatrick LLP633 W. 5th Street, 36th FloorLos Angeles, CA 90071UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Cosmetic preparation for skin care; Cosmetic preparations for hair and scalp; Cosmetic preparations for bath and shower; Cosmetic preparations for protecting the skin from the UV rays; Cosmetic topical patch for skin care; Cosmetic products taken orally, namely, pills that induce bronzing of the skin; Cosmetic preparations in the form of dermal patches comprising essential oils; Non-medicated topical cosmetic creams and gels; Non-medicated topical cosmetic creams and gels for the prevention and treatment of scar tissue; Inhalers in the nature of nasal strips filled with essential oils for sleep disorders, weight loss, and stress relief which are inhaled by the user, not for medical or therapeutic useACTIVE—
005Non-medical topical transdermal patch featuring vitamins and mineral supplements for vitamin and mineral delivery; Non-medical dermal patch featuring vitamins and mineral supplements for vitamin and mineral delivery; Non-medical topical transdermal patch for prevention of erectile dysfunction; Non-medical topical transdermal patch for prevention of insomnia; Non-medical topical transdermal patch for prevention of hangovers; Non-medical topical transdermal patch for prevention of scar tissue formation; Inhalers in the nature of nasal strips filled with pharmaceutical preparations for sleep disorders, weight loss, and stress relief which are inhaled by the user; Non-medical sublingual for the delivery of vitamins and minerals, namely, delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; Medical topical transdermal patch featuring vitamins and mineral supplements for vitamin and mineral delivery; Medical dermal patch featuring vitamins and mineral supplements for vitamin and mineral delivery; Medical topical transdermal patch for prevention of erectile dysfunction; Medical topical transdermal patch for prevention of insomnia; Medical topical transdermal patch for prevention of hangovers; Medical topical transdermal patch for prevention of scar tissue formation; Medicated topical creams and gels for treatment of ____indicate specific disease or condition; Medicated topical creams and gels for the prevention and treatment of scar tissue; Inhalers in the nature of nasal strips filled with pharmaceutical preparations for sleep disorders, weight loss, and stress relief which are inhaled by the user; Medical sublingual for deliver of pharmaceuticals, namely, drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparationsACTIVE—
010Transdermal Drug Delivery System, namely, transdermal drug delivery patches sold without medication; Drug Delivery Patches sold without medicationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Apr 4, 2018MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 4, 2018ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 6, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 9, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2017ALIEASSIGNED TO LIE—
Jul 4, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 4, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2016DOCKASSIGNED TO EXAMINER—
Dec 29, 2016DOCKASSIGNED TO EXAMINER—
Sep 27, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 26, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance